InvestorsHub Logo
Followers 28
Posts 849
Boards Moderated 0
Alias Born 04/14/2015

Re: kwisatzhaderach post# 8769

Thursday, 07/27/2017 11:43:31 AM

Thursday, July 27, 2017 11:43:31 AM

Post# of 21373
Reverse merger was approved by Oncolix board.

No dilution, no RS!

8 patents, FDA orphan drug designation Prolanta phase 1, $15M VC & big pharma exec investor

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.